fangxianuo / iStockphoto.com
Anthony Atala combines the roles of surgeon and researcher in regenerative medicine, allowing him to stay mindful of why his work is important. He talks to LSIPR about his twin professions.
While most people in the life sciences industry pick one vocation, Anthony Atala is one of the few who has successfully forged two careers in one field. Atala is a practising surgeon and a researcher in the area of regenerative medicine at the Wake Forest Institute for Regenerative Medicine (WFIRM), a US-based institute for translating scientific discovery into clinical therapies.
Atala tells LSIPR that his twin roles as surgeon and researcher help him improve in each pursuit.
“Treating patients keeps me focused on the long-term results of our regenerative medicine research to bring healing therapies and technologies to fruition,” he says.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
Anthony Atala, Wake Forest Institute for Regenerative Medicine, LSIPR 50, regenerative medicine, solid organs, technologies, clinical therapies,